News
With increased US competition from FY26, DRL plans portfolio shifts, inorganic growth, cost control and global expansion to ...
KFDX Wichita Falls on MSN11h
United Regional Physician Group teams with Dr. Reddy to open cancer centerWhy Adding More Bananas to Your Diet Could Impact Your Blood Pressure ...
United Regional is growing its medical team and expanding its oncology services with the addition of Medical Oncologist and ...
The United Regional Physician Group has announced the addition of a highly respected and esteemed oncologist to their group.
17d
Stocktwits on MSNDr Reddy’s Breaks Past ₹1,330 Apex: SEBI RA Rajneesh Sharma Sees Trend Shift, Cautions Overbought ZoneDr. Reddy’s Laboratories Ltd has broken out of a volatility contraction base (VCB) pattern that developed over the past 7–8 ...
Alvotech and Dr. Reddy’s have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Merck Sharp & Dohme’s Keytruda (pembrolizumab) ...
7d
NDTV Profit on MSNDr. Reddy's Shares Decline After Citi Reduces Target Price Amid Growth ConcernsCiti expressed caution on the growth outlook, particularly around the Canadian GLP-1 market and the highly anticipated launch ...
Dr. Reddy's Laboratories Ltd. closed 5.83% below its 52-week high of 1,420.20 rupees, which the company reached on August ...
Dr. Reddy's Laboratories Ltd. closed 6.60% below its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results